An Efficacy and Safety Study of Escitalopram Long-Term Treatment in Major Depressive Disorder With Associated Anxiety Symptoms

Clinical trial NCT01814098 · COMPLETED

Trial details

NCT number: NCT01814098
Sponsor: Xian-Janssen Pharmaceutical Ltd.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Depressive Disorder, Major

Start date: 2009-07-07
Primary completion: 2011-05-31
Enrollment: 318

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.